Other furin inhibitors, including diminazene, are currently being evaluated for efficacy against COVID-19, suggesting that withholding furin from the SARS-CoV-2 virus may comprise a valuable therapeutic strategy (AbdelMassih et al., 2020; Wu et al., 2020). Here, FURIN is linked to COVID-19.